Exhibiting at Fi South America 2025

Intermeios Distribuidora de Insumos Farmacêuticos Ltda. is a Brazilian-based distributor and importer of pharmaceutical raw materials with strategic operations across Latin America. Headquartered in Anápolis, Goiás, with a secondary unit in Campinas, São Paulo, Intermeios serves pharmaceutical, veterinary, cosmetic, and food industries through a robust portfolio of active pharmaceutical ingredients (APIs), excipients, and specialty ingredients. The company is part of a broader global partnership structure that connects Latin American markets with Asian manufacturing hubs, particularly in India and China.

Company Background

Founded in 2006, Intermeios emerged with the purpose of bridging the gap between high-quality international ingredient manufacturers and the demanding compliance and logistics environment of Brazil’s regulated industries. With backing from Indian investors and a team experienced in pharmaceutical sourcing and logistics, Intermeios has grown into a reliable import and distribution platform for critical pharmaceutical inputs.

The company’s business model integrates supplier qualification, regulatory compliance, inventory management, and B2B distribution, offering a full-service model for its regional clients.

Core Business

Intermeios specializes in:

• Import and distribution of APIs and pharmaceutical excipients
• Custom sourcing and regulatory support for pharmaceutical and veterinary formulation companies
• Warehousing and supply chain integration for local Brazilian manufacturers
• Cosmetic and food ingredient supply, with growing expansion in these verticals

The company’s offering spans multiple regulated sectors including human medicine, animal health, dermocosmetics, and nutraceuticals.

Product and Service Offerings

Key Product Categories

• APIs (Active Pharmaceutical Ingredients):
  • Antibiotics, antivirals, antidiabetics, cardiovascular compounds, antifungals, anti-inflammatory agents, CNS-related APIs
• Pharmaceutical Excipients:
  • Lactose, microcrystalline cellulose, starch derivatives, binders, and coating agents
• Cosmetic Actives & Bases:
  • Natural extracts, humectants, vitamins, and essential oils
• Food Grade Additives:
  • Preservatives, flavor enhancers, colorants, and emulsifiers

Services

• Import documentation and logistics handling
• Regulatory compliance: ANVISA support and dossier preparation
• Supplier qualification and technical audit coordination
• Demand planning and local stock availability
• Technical consulting for formulation and substitution

Specialization and Core USP

Intermeios provides unique value through:

• Bilateral sourcing partnerships with certified Indian and Chinese manufacturers
• Multi-sector capability, serving both pharmaceutical and non-pharma verticals
• In-house regulatory expertise to support compliance with Brazilian health authority ANVISA
• Stock-and-serve model offering reduced lead times and on-demand availability
• Cross-border support through Intermeios México S.A. de C.V., expanding reach into Latin America

Financial Overview

While Intermeios operates as a private enterprise and does not disclose public financials, trade data reveals:

• 62 documented import shipments from India between 2021 and 2024
• Total import value exceeding USD 1.06 million, primarily in organic pharmaceutical compounds
• Estimated annual sales between BRL 12 to 20 million, derived from wholesale pharmaceutical contracts and distribution agreements

Key clients include generic drug manufacturers, compounding pharmacies, animal health companies, and cosmetic OEMs.

Export and Shipment Records

Trade and customs data from Trademo and ImportGenius indicate:

• Top import partners: India (majority), China, and Germany
• Most frequently imported items: Heterocyclic compounds, vitamins, anti-infective agents
• Port of entry: Primarily Port of Santos (SP) and Viracopos International Airport (Campinas)
• Intermeios holds active import registration with RADAR (Receita Federal) and SISCOMEX, complying with Brazil’s import control framework

Target Markets

• Pharmaceutical manufacturing plants (OTC and Rx drugs)
• Veterinary drug and supplement manufacturers
• Dermocosmetic labs and personal care producers
• Food ingredient formulators and nutraceutical brands
• Pharmacies with compounding labs

Operational Capabilities

• Campinas office and warehouse located near Viracopos Airport for rapid logistics execution
• Anápolis headquarters positioned within Brazil’s pharmaceutical hub (home to Biolab, Neo Química, etc.)
• Inventory management system capable of supporting JIT (Just-In-Time) supply agreements
• Cold chain logistics partnerships for thermosensitive APIs

Certifications and Compliance

• ANVISA-compliant documentation for all regulated APIs
• GMP certificates sourced from international partners (India, EU, China)
• ISO 9001 process adherence for internal operations (in progress)
• Complies with Brazil’s RDC 301/2019 and RDC 430/2020 for pharmaceutical import and storage
• Legal entity registered with CNPJ and Receita Federal

Customer Testimonials

“Intermeios helped us localize a hard-to-source API from India with full regulatory support. Their responsiveness and supply consistency have made them our go-to importer for specialized raw materials.”
— Head of Procurement, Generic Pharmaceutical Company, São Paulo

Major Achievements

• Successfully expanded operations to Intermeios México S.A. de C.V. for regional expansion
• Managed importation and distribution of APIs for over 80 pharmaceutical clients in Brazil
• Recognized in 2021 as a Top Regional Importer of Specialty Organic Compounds by trade monitoring platforms
• Implemented a local inventory program in Campinas, reducing delivery time from 40 to 7 days
• Partnered with over 25 API manufacturers across Asia and Europe

Intermeios continues to consolidate its leadership as a reliable intermediary in Brazil’s complex pharmaceutical supply chain, offering technical, regulatory, and commercial value to clients navigating a fast-evolving health ingredients market.